Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Safety Changes: Pulmicort Flexhaler, Atripla, Aptivus
Link ID 8776
Title FDA Safety Changes: Pulmicort Flexhaler, Atripla, Aptivus
Url http://www.medscape.com/viewarticle/580654?src=rss
Description The FDA has approved revisions to safety labeling for budesonide inhalation powder, efavirenz plus emtricitabine and tenofovir disoproxil fumarate tablets, and tipranavir capsules and oral solution. Medscape Medical News
Category Articles > Allergy and Clinical Immunology
Keywords
Date Sep 19, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Allergy and Clinical Immunology
1. IL-2 Immunotoxin Boosts Vaccine-Mediated T-Cell Immunity
  The interleukin 2 (IL-2) immunotoxin denileukin diftitox reduces regulatory T cells (Tregs) and thus enhances vaccine-mediated T-cell immunity, according to findings in murine studies. Reuters Health Information
Category:   Articles > Allergy and Clinical Immunology


2. Highlights of the American College of Allergy, Asthma and Immunology (ACAAI) 2007 Annual Meeting
  ACAAI 2007: Review clinically focused discussions on the new treatments and management strategies for patients with asthma and anaphylaxis. Medscape Allergy & Clinical Immunology
Category:   Articles > Allergy and Clinical Immunology


3. Guidelines Updated for Administration of Combination MMRV Vaccine
  The Advisory Committee on Immunization Practices no longer prefers administering combination measles, mumps, rubella, and varicella vaccine vs separate injections of equivalent component vaccines. Medscape Medical News
Category:   Articles > Allergy and Clinical Immunology


4. Needle-Length Guidelines for Thigh and Shoulder Vaccinations May Need Revision
  When current Centers for Disease Control and Prevention recommendations for vaccination needle lengths are used, there is a substantial risk for overpenetration of the intramuscular layer. Medscape Medical News
Category:   Articles > Allergy and Clinical Immunology


5. New C1 Esterase Inhibitor Is Highly Effective in Hereditary Angioedema
  An investigational C1 esterase inhibitor (Berinert, CSL Behring, King of Prussia, PA) is "highly effective and well tolerated" for the treatment of acute abdominal and facial attacks in patients with hereditary angioedema (HAE). Reuters Health Information
Category:   Articles > Allergy and Clinical Immunology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS